JESSICA CHRISTENSEN: Open Payments
NPI 1285136507 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 39 payments from 10 companies in 2025. Trend: 2023 $2,067 · 2024 $1,445 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $229 |
| GENZYME CORPORATION | 6 | $163 |
| LEO Pharma Inc. | 7 | $141 |
| E.R. Squibb & Sons, L.L.C. | 2 | $135 |
| ABBVIE INC. | 3 | $57 |
| Incyte Corporation | 2 | $48 |
| Organon LLC | 4 | $30 |
| Janssen Biotech, Inc. | 1 | $29 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
Products named: COSENTYX, DUPIXENT, Sotyktu, ADBRY, OPZELURA, ANZUPGO, Rhapsido, TREMFYA.
Industry payments across CA — which companies pay providers there.
